 - Patients in accelerated phase will meet one or more of the following criteria: greater than or equal to 15 through less than 30 blasts in peripheral blood or bone marrow, greater than or equal to 30 blasts promyelocytes in peripheral blood or bone marrow, greater than or equal to 20 basophils in peripheral blood, platelet count less than 100109L unrelated to therapy or clonal evolution. 